ArticleThe Journal of clinical investigation2019

Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression.

Lucia Poncette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.